("hydroxyurea"[MeSH Terms] OR hydroxyurea[Text Word])

Phase II open label trial of imatinib in polycythemia rubra vera.

Jones CM, Dickinson TM, Salvado A.

Int J Hematol. 2008 Nov 15. [Epub ahead of print]

PMID: 19009241 [PubMed - as supplied by publisher]

Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy.

Lanaro C, Franco-Penteado CF, Albuqueque DM, Saad ST, Conran N, Costa FF.

J Leukoc Biol. 2008 Nov 12. [Epub ahead of print]

PMID: 19004988 [PubMed - as supplied by publisher]

Apoptosis-resistant NS/0 E1B-19K myelomas exhibit increased viability and chimeric antibody productivity under cell cycle modulating conditions.

Mercille S, Massie B.

Cytotechnology. 1998 Nov;28(1-3):189-203.

PMID: 19003420 [PubMed - in process]

The spleen in the sickling disorders: an update.

Khatib R, Rabah R, Sarnaik SA.

Pediatr Radiol. 2008 Nov 11. [Epub ahead of print]

PMID: 19002450 [PubMed - as supplied by publisher]

Hemoglobin research and the origins of molecular medicine.

Schechter AN.

Blood. 2008 Nov 15;112(10):3927-38.

PMID: 18988877 [PubMed - in process]

ATRMec1 phosphorylation-independent activation of Chk1 in vivo.

Chen Y, Caldwell JM, Pereira E, Baker RW, Sanchez Y.

J Biol Chem. 2008 Nov 4. [Epub ahead of print]

PMID: 18984588 [PubMed - as supplied by publisher]

Chk1 phosphorylation at Ser286 and Ser301 occurs with both stalled DNA replication and damage checkpoint stimulation.

Ikegami Y, Goto H, Kiyono T, Enomoto M, Kasahara K, Tomono Y, Tozawa K, Morita A, Kohri K, Inagaki M.

Biochem Biophys Res Commun. 2008 Nov 5. [Epub ahead of print]

PMID: 18983824 [PubMed - as supplied by publisher]

Hodgkin lymphoma in a sickle cell anaemia child treated with hydroxyurea.

Couronné L, Schneider P, de Montalembert M, Dumesnil C, Lahary A, Vannier JP.

Ann Hematol. 2008 Nov 1. [Epub ahead of print] No abstract available.

PMID: 18979099 [PubMed - as supplied by publisher]

Use of hydroxyurea from childhood to adult age in sickle cell disease: semen analysis.

Lukusa AK, Vermylen C.

Haematologica. 2008 Nov;93(11):e67; discussion e68. No abstract available.

PMID: 18978293 [PubMed - indexed for MEDLINE]

10:

Synthesis and ribonucleotide reductase inhibitory activity of thiosemicarbazones.

Krishnan K, Prathiba K, Jayaprakash V, Basu A, Mishra N, Zhou B, Hu S, Yen Y.

Bioorg Med Chem Lett. 2008 Dec 1;18(23):6248-50. Epub 2008 Oct 2.

PMID: 18976907 [PubMed - in process]

11:

Can Homeopathy Bring Additional Benefits to Thalassemic Patients on Hydroxyurea Therapy? Encouraging Results of a Preliminary Study.

Banerjee A, Chakrabarty SB, Karmakar SR, Chakrabarty A, Biswas SJ, Haque S, Das D, Paul S, Mandal B, Naoual B, Belon P, Khuda-Bukhsh AR.

Evid Based Complement Alternat Med. 2007 Oct 29. [Epub ahead of print]

PMID: 18955271 [PubMed - as supplied by publisher]

12:

Hydroxyurea in sickle cell disease - A study of clinico-pharmacological efficacy in the Indian haplotype.

Italia K, Jain D, Gattani S, Jijina F, Nadkarni A, Sawant P, Nair S, Mohanty D, Ghosh K, Colah R.

Blood Cells Mol Dis. 2008 Oct 25. [Epub ahead of print]

PMID: 18954999 [PubMed - as supplied by publisher]

13:

Acido-base behavior of hydroxamic acids: experimental and ab initio studies on hydroxyureas.

Vrcek IV, Kos I, Weitner T, Birus M.

J Phys Chem A. 2008 Nov 20;112(46):11756-68. Epub 2008 Oct 25.

PMID: 18950143 [PubMed - in process]

14:

[Practical approach to hypereosinophilia]

Roufosse F, Cogan E.

Rev Med Brux. 2008 Sep;29(4):400-8. French.

PMID: 18949995 [PubMed - in process]

15:

Arterial spin-labeled perfusion combined with segmentation techniques to evaluate cerebral blood flow in white and gray matter of children with sickle cell anemia.

Helton KJ, Paydar A, Glass J, Weirich EM, Hankins J, Li CS, Smeltzer MP, Wang WC, Ware RE, Ogg RJ.

Pediatr Blood Cancer. 2009 Jan;52(1):85-91.

PMID: 18937311 [PubMed - as supplied by publisher]

16:

Randomized Trial of Postoperative Reirradiation Combined With Chemotherapy After Salvage Surgery Compared With Salvage Surgery Alone in Head and Neck Carcinoma.

Janot F, de Raucourt D, Benhamou E, Ferron C, Dolivet G, Bensadoun RJ, Hamoir M, Géry B, Julieron M, Castaing M, Bardet E, Grégoire V, Bourhis J.

J Clin Oncol. 2008 Oct 20. [Epub ahead of print]

PMID: 18936479 [PubMed - as supplied by publisher]

17:

Overexpression of high molecular weight FGF-2 forms inhibits glioma growth by acting on cell-cycle progression and protein translation.

Lemiere S, Azar R, Belloc F, Gürsel D, Pyronnet S, Bikfalvi A, Auguste P.

Exp Cell Res. 2008 Oct 7. [Epub ahead of print]

PMID: 18930044 [PubMed - as supplied by publisher]

18:

Localization of Smc5/6 to centromeres and telomeres requires heterochromatin and SUMO, respectively.

Pebernard S, Schaffer L, Campbell D, Head SR, Boddy MN.

EMBO J. 2008 Nov 19;27(22):3011-3023. Epub 2008 Oct 16.

PMID: 18923417 [PubMed - as supplied by publisher]

19:

BLAP18/RMI2, a novel OB-fold-containing protein, is an essential component of the Bloom helicase-double Holliday junction dissolvasome.

Singh TR, Ali AM, Busygina V, Raynard S, Fan Q, Du CH, Andreassen PR, Sung P, Meetei AR.

Genes Dev. 2008 Oct 15;22(20):2856-68.

PMID: 18923083 [PubMed - in process]

20:

Hydroxyurea in old patients with essential thrombocythemia.

Randi ML, Ruzzon E, Piccoli A, Tezza F, Scapin M, Scandellari R, Fabris F.

Aging Clin Exp Res. 2008 Aug;20(4):376-80.

PMID: 18852553 [PubMed - in process]

Recent Activity